Co-designing a behavioural intervention for reducing the impact of chemotherapy-induced peripheral neuropathy symptoms: An evidence- and theory-driven approach.
Common Sense Model
cancer
chemotherapy
chemotherapy-induced peripheral neuropathy
experience-based co-design
intervention development
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
22
06
2022
received:
11
01
2022
accepted:
28
07
2022
pubmed:
13
8
2022
medline:
30
11
2022
entrez:
12
8
2022
Statut:
ppublish
Résumé
This study aims to co-design an evidence- and theory-based behavioural intervention to reduce the impact of chemotherapy-induced peripheral neuropathy (CIPN) symptoms on patients' quality of life. Guided by the Medical Research Council Framework for developing and evaluating complex interventions, our intervention development process was guided by (a) findings of systematic reviews, (b) inductive analysis of 39 h of observational fieldwork, 12 patient and 11 clinician interviews, (c) deductive analysis using the Common-Sense Model to develop a Self-Regulation Model of CIPN and (d) 17 patients and 18 clinicians co-designing the intervention. CIPN perception and coping behaviours were highlighted as processes to target when co-designing an intervention. The processes targeted in our intervention are CIPN perception and coping behaviours, namely, (a) self-monitoring of symptoms, (b) communicating and early reporting of symptoms to clinicians, (c) participating in making chemotherapy dose reduction decisions with their clinicians and (d) engaging in self-management and safety strategies to reduce impact of CIPN symptoms. To address these, a behavioural intervention was deemed suitable. We developed a self-regulation model of CIPN and a logic model for documenting the proposed mechanism of action of our co-designed behavioural intervention for reducing impact of CIPN symptoms.
Identifiants
pubmed: 35959639
doi: 10.1111/ecc.13671
pmc: PMC9786800
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Observational Study
Journal Article
Langues
eng
Pagination
e13671Subventions
Organisme : National Institute for Health Research
ID : DRF-2018-11-ST2-017
Informations de copyright
© 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.
Références
Nurs Res. 2007 Sep-Oct;56(5):323-31
pubmed: 17846553
Eur J Cancer Care (Engl). 2019 May;28(3):e13011
pubmed: 30790382
CA Cancer J Clin. 2013 Nov-Dec;63(6):419-37
pubmed: 24590861
Cancer Med. 2020 Mar;9(5):1733-1740
pubmed: 31957269
Eur J Cancer Care (Engl). 2022 Jan;31(1):e13517
pubmed: 34643016
BMJ Open. 2020 Apr 8;10(4):e033516
pubmed: 32273313
Cancer Nurs. 2005 Sep-Oct;28(5):382-9
pubmed: 16192830
BMC Cancer. 2016 Nov 25;16(1):919
pubmed: 27884127
Ann Oncol. 2020 Oct;31(10):1306-1319
pubmed: 32739407
J Orthop Sports Phys Ther. 2017 Sep;47(9):628-636
pubmed: 28704621
BMJ Open. 2019 Aug 15;9(8):e029954
pubmed: 31420394
J Natl Cancer Inst. 2002 Apr 17;94(8):558-84
pubmed: 11959890
Qual Health Res. 2016 Nov;26(13):1802-1811
pubmed: 27340178
BMJ. 2015 Feb 10;350:g7714
pubmed: 25670179
BMJ Qual Saf. 2020 Jan;29(1):64-76
pubmed: 31548278
Clin J Oncol Nurs. 2010 Jun;14(3):E22-8
pubmed: 20529785
Comput Inform Nurs. 2016 Jul;34(7):322-9
pubmed: 27116414
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Clin Oncol. 2014 Jan 20;32(3):199-205
pubmed: 24344222
Evid Rep Technol Assess (Summ). 2004 Jun;(102):1-8
pubmed: 15307691
J Pain. 2018 Apr;19(4):382-394
pubmed: 29229430
Ann Behav Med. 2019 Jul 17;53(8):693-707
pubmed: 30304386
J Clin Oncol. 2008 Dec 20;26(36):5855-62
pubmed: 19029420
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Syst Rev. 2019 Dec 13;8(1):324
pubmed: 31836007
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13671
pubmed: 35959639
J Clin Oncol. 2020 Oct 1;38(28):3325-3348
pubmed: 32663120
J Natl Cancer Inst. 2001 Jun 6;93(11):810-23
pubmed: 11390531
J Behav Med. 2016 Dec;39(6):935-946
pubmed: 27515801
Support Care Cancer. 2020 Sep;28(9):4163-4172
pubmed: 31897779
BMC Health Serv Res. 2012 Aug 22;12:271
pubmed: 22913525
J Palliat Med. 2010 Nov;13(11):1389-91
pubmed: 21091028
J Adv Pract Oncol. 2015 Jan-Feb;6(1):54-6
pubmed: 26413374
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 26786536
J Cancer Surviv. 2021 Mar 12;:
pubmed: 33710510
Support Care Cancer. 2015 Oct;23(10):3069-80
pubmed: 25744288
BMC Cancer. 2018 Dec 4;18(1):1203
pubmed: 30514351
Health Care Anal. 2018 Jun;26(2):171-188
pubmed: 29038985
Health Expect. 2021 Apr;24(2):188-197
pubmed: 33528082
Br J Health Psychol. 2008 May;13(Pt 2):195-204
pubmed: 18331667